Selena Mimmi

1.2k total citations
33 papers, 798 citations indexed

About

Selena Mimmi is a scholar working on Molecular Biology, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Selena Mimmi has authored 33 papers receiving a total of 798 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 8 papers in Genetics and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Selena Mimmi's work include Chronic Lymphocytic Leukemia Research (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Glycosylation and Glycoproteins Research (6 papers). Selena Mimmi is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Glycosylation and Glycoproteins Research (6 papers). Selena Mimmi collaborates with scholars based in Italy, United States and Belgium. Selena Mimmi's co-authors include Enrico Iaccino, Ileana Quinto, Domenico Maisano, Giuseppe Fiume, Eleonora Vecchio, Vincenzo Dattilo, Giuseppe Scala, Antonio Pisano, F. Albano and Gaetanina Golino and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and The FASEB Journal.

In The Last Decade

Selena Mimmi

32 papers receiving 787 citations

Peers

Selena Mimmi
Rosey Mushens United Kingdom
Tian Tian China
Sonali P. Barwe United States
Geeta Upadhyay United States
Xiong Jin South Korea
Stephanie T. Murphy United States
Rosey Mushens United Kingdom
Selena Mimmi
Citations per year, relative to Selena Mimmi Selena Mimmi (= 1×) peers Rosey Mushens

Countries citing papers authored by Selena Mimmi

Since Specialization
Citations

This map shows the geographic impact of Selena Mimmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Selena Mimmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Selena Mimmi more than expected).

Fields of papers citing papers by Selena Mimmi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Selena Mimmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Selena Mimmi. The network helps show where Selena Mimmi may publish in the future.

Co-authorship network of co-authors of Selena Mimmi

This figure shows the co-authorship network connecting the top 25 collaborators of Selena Mimmi. A scholar is included among the top collaborators of Selena Mimmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Selena Mimmi. Selena Mimmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mimmi, Selena, Costanza Maria Cristiani, Anna Maria Tolomeo, et al.. (2025). Neurofilament Light Chain from Neuronally Derived Extracellular Vesicles in Differentiating Parkinson’s Disease from Essential Tremor with Resting Tremor. Molecular Neurobiology. 63(1). 24–24.
2.
Vecchio, Eleonora, Selena Mimmi, Maria Rosaria Ruocco, et al.. (2025). FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma. Communications Biology. 8(1). 324–324. 2 indexed citations
3.
Cristiani, Costanza Maria, Selena Mimmi, Elvira Immacolata Parrotta, et al.. (2025). Neuronally Derived Extracellular Vesicles’ Oligomeric and p129-α-Synuclein Levels for Differentiation of Parkinson’s Disease from Essential Tremor. International Journal of Molecular Sciences. 26(8). 3819–3819. 1 indexed citations
4.
Vecchio, Eleonora, Selena Mimmi, Alessandro Arcucci, et al.. (2024). Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells. Frontiers in Oncology. 14. 1339584–1339584. 2 indexed citations
5.
Aloisio, Annamaria, Antonio Lupia, Selena Mimmi, et al.. (2023). Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype. Cells. 12(7). 1078–1078. 10 indexed citations
6.
Mimmi, Selena, Erika Cione, Annamaria Aloisio, et al.. (2023). SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections. Clinical Chemistry and Laboratory Medicine (CCLM). 61(8). 1518–1524. 27 indexed citations
7.
Mimmi, Selena, Nicola Lombardo, Domenico Maisano, et al.. (2022). Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence. Genes. 13(12). 2366–2366. 8 indexed citations
8.
Trimboli, Francesca, et al.. (2021). Serum 25-hydroxyvitamin D measurement: Comparative evaluation of three automated immunoassays. Practical Laboratory Medicine. 26. e00251–e00251. 10 indexed citations
9.
Maisano, Domenico, Enrico Iaccino, Alessandro d’Ambrosio, et al.. (2021). Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations. Frontiers in Oncology. 11. 703254–703254. 1 indexed citations
10.
Mimmi, Selena, Domenico Maisano, Eleonora Vecchio, et al.. (2020). Detection of chronic lymphocytic leukemia subpopulations in peripheral blood by phage ligands of tumor immunoglobulin B cell receptors. Leukemia. 35(2). 610–614. 12 indexed citations
11.
Maisano, Domenico, Selena Mimmi, Rossella Russo, et al.. (2020). Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring. Pharmaceuticals. 13(8). 180–180. 38 indexed citations
12.
Lupia, Antonio, Selena Mimmi, Enrico Iaccino, et al.. (2019). Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia. European Journal of Medicinal Chemistry. 185. 111838–111838. 18 indexed citations
13.
Vecchio, Eleonora, Gaetanina Golino, Antonio Pisano, et al.. (2019). IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis. Cell Death and Disease. 10(4). 320–320. 21 indexed citations
14.
Mimmi, Selena, Domenico Maisano, Ileana Quinto, & Enrico Iaccino. (2018). Phage Display: An Overview in Context to Drug Discovery. Trends in Pharmacological Sciences. 40(2). 87–91. 81 indexed citations
15.
Albano, F., Federico Chiurazzi, Selena Mimmi, et al.. (2018). The expression of inhibitor of bruton’s tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis. Cell Death and Disease. 9(1). 13–13. 27 indexed citations
16.
Serra, Raffaele, Luca Gallelli, Lucia Butrico, et al.. (2016). From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases. International Wound Journal. 14(1). 233–240. 39 indexed citations
17.
Pisano, Antonio, Simona Ceglia, Camillo Palmieri, et al.. (2015). CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation. Journal of Biological Chemistry. 290(22). 13958–13971. 21 indexed citations
19.
Fiume, Giuseppe, Annalisa Rossi, Annamaria de Laurentiis, et al.. (2013). Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-κB. PLoS ONE. 8(6). e66087–e66087. 17 indexed citations
20.
Causa, Filippo, Enrico Iaccino, Selena Mimmi, et al.. (2012). Evolutionary screening and adsorption behavior of engineered M13 bacteriophage and derived dodecapeptide for selective decoration of gold interfaces. Journal of Colloid and Interface Science. 389(1). 220–229. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026